Literature DB >> 20667857

Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population.

M Schuur1, J C van Swieten, S Schol-Gelok, M A Ikram, M W Vernooij, F Liu, A Isaacs, R de Boer, I de Koning, W J Niessen, H Vrooman, B A Oostra, A van der Lugt, M M B Breteler, C M van Duijn.   

Abstract

BACKGROUND: Asymptomatic cerebral lesions on MRI such as white matter lesions (WML), lacunes and microbleeds are commonly seen in older people. We examined the role of a series of candidate genes involved in blood pressure regulation and amyloid metabolism.
MATERIALS AND METHODS: The study was embedded in a family-based cohort sampled from a Dutch genetically isolated population. We selected individuals between 55 and 75 years of age with hypertension (N=129). Volumes of WML and presence of lacunes and microbleeds were assessed with MRI. We studied three genes involved in blood pressure regulation (angiotensin, angiotensin II type 1 receptor, α-adducin) and two genes involved in the amyloid pathway (apolipoprotein E (APOE) and sortilin-related receptor gene (SORL1)).
RESULTS: All participants had WML (median volume, 3.1 ml; interquartile range, 1.5-6.5 ml); lacunar infarcts were present in 15.5% and microbleeds in 23.3%. Homozygosity for the APOE ε4 allele was associated with lacunes (OR, 4.8; 95% CI, 1.2 to 19.3). Individuals carrying two copies of the variant allele of four single nucleotide polymorphism (SNPs) located at the 3'-end of SORL1 (rs1699102, rs3824968, rs2282649, rs1010159) had significantly more often microbleeds (highest OR, 6.87; 95% CI, 1.78 to 26.44).
CONCLUSION: The association of SORL1 with microbleeds suggests that the amyloid cascade is involved in the aetiology of microbleeds in populations with hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667857     DOI: 10.1136/jnnp.2009.176362

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

Review 1.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

2.  Genome-Wide Association Study of Cerebral Microbleeds on MRI.

Authors:  Hong-Qi Li; Wen-Jie Cai; Xiao-He Hou; Mei Cui; Lan Tan; Jin-Tai Yu; Qiang Dong
Journal:  Neurotox Res       Date:  2019-06-18       Impact factor: 3.911

Review 3.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

4.  APOE ε4 and late-life cognition: mediation by structural brain imaging markers.

Authors:  Yuan Ma; Gautam Sajeev; Tyler J VanderWeele; Anand Viswanathan; Sigurdur Sigurdsson; Gudny Eiriksdottir; Thor Aspelund; Rebecca A Betensky; Francine Grodstein; Albert Hofman; Vilmundur Gudnason; Lenore Launer; Deborah Blacker
Journal:  Eur J Epidemiol       Date:  2022-04-26       Impact factor: 12.434

Review 5.  A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Biol Psychiatry       Date:  2013-11-28       Impact factor: 13.382

Review 6.  Genetics of subcortical vascular dementia.

Authors:  Helena Schmidt; Paul Freudenberger; Stephan Seiler; Reinhold Schmidt
Journal:  Exp Gerontol       Date:  2012-06-23       Impact factor: 4.032

7.  Neuroimaging measures as endophenotypes in Alzheimer's disease.

Authors:  Meredith N Braskie; John M Ringman; Paul M Thompson
Journal:  Int J Alzheimers Dis       Date:  2011-03-31

8.  Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease.

Authors:  Aleksandra M Pavlovic; Tatjana Pekmezovic; Jasna Zidverc Trajkovic; Gordana Tomic; Edita Cvitan; Nada Sternic
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-29       Impact factor: 3.738

9.  Nigella sativa and Its Protective Role in Oxidative Stress and Hypertension.

Authors:  Xin-Fang Leong; Mohd Rais Mustafa; Kamsiah Jaarin
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-07       Impact factor: 2.629

Review 10.  Cerebral small vessel disease and Alzheimer's disease.

Authors:  Zhiyou Cai; Chuanling Wang; Wenbo He; Hanjun Tu; Zhengang Tang; Ming Xiao; Liang-Jun Yan
Journal:  Clin Interv Aging       Date:  2015-10-23       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.